417. Sharif S. Regulation of immune responses by natural killer T cells / S. Sharif,
T.L. Delovitch // Arch. Immunol. Ther. Exp. (Warsz). - 2001. - Vol. 49. - P.
823-31.
418. Shephard P.R. Glucose transporters and insulin action: implications for insulin
resistance and diabetes mellitus / P.R. Shephard, B.B. Kahn // N. Engl. J. Med.
-1999 .-V o l. 341.- P . 248-251.
419. Shoemaker W.C. Measurement of tissue perfusion by oxygen transport
patterns in experimental shock and in high-risk surgical patients / W.C.
*
Shoemaker, P.L. Appel // Intensive Care Med. - 1990. - Vol. 16. - P. 135-144.
420. Shoemaker W.C. Oxygen transport measurements to evaluate tissue perfusion
and titrate therapy: dobutamine and dopamine effects / W.C. Shoemaker, P.L.
Appel, H.B. Kram // Crit. Care Med. - 1991. - Vol. 5. - P. 672-688.
421. Shoemaker W.C. Hemodynamic and oxygen transport patterns for outcome
prediction, therapeutic goals, and clinical algorithms to improve outcome.
Feasibility of artificial intelligence to customize algorithms / W.C. Shoemaker,
R. Patil, P.L. Appel // Chest. - 1992. - Vol. 5. - P. 17-625.
422. Shoemaker W.C. Hemodynamic and oxygen transport monitoring to titrate
therapy in septic shock / W.C. Shoemaker, P.L. Appel, H.B. Kram et al. // New
Horiz.- 1 9 9 3 -Vol. 1, № 1. - P. 145-159.
423. Shoemaker W.C. Temporal hemodynamic and oxygen transport patterns in
medical patients. Septic shock / W.C. Shoemaker, P.L. Appel, H.B. Kram //
Chest. - 1 9 9 3 . -V o l . l l .-P . 1529-1536.
424. Shoemaker W.C. Hemodynamic and oxygen transport monitoring to titrate
therapy in septic shock / W.C. Shoemaker, P.L. Appel, H.B. Kram et al. //
New. Horiz. - 1993.-V o l. l . - P . 145-59.
425. Shoemaker W.C. Pathophysiology, monitoring and therapy of acute circulatory
problems / W.C. Shoemaker // Crit. Care Nurs. Clin. North. Am. - 1994. -
Vol. 6, № 2. - P. 295-307.
383
